Zscaler Introduces Innovations in Intelligent Segmentation to Extend Zero Trust to Branches, Factories and Clouds
SAN JOSE, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) — Zscaler, Inc. (NASDAQ: ZS), the leader in cloud security, today announced […]
Allegro MicroSystems Introduces Advanced Magnetic and Inductive Position Sensing Solutions at Electronica 2024
MANCHESTER, N.H., Nov. 12, 2024 (GLOBE NEWSWIRE) — Allegro MicroSystems, Inc. (“Allegro”) (Nasdaq: ALGM), a global leader in power and […]
NXP Announces Industry-First Ultra-Wideband Wireless Battery Management System Solution
NXP’s Ultra-Wideband (UWB) wireless battery management system (BMS) simplifies EV assembly, enables increased battery energy density and decouples mechanical and […]
NXP’s New i.MX 94 Family of Applications Processors Delivers Safe, Secure Connectivity for the Industrial and Automotive Edge
Enable industrial control by combining real-time processing with support for industrial networking protocols in NXP’s first i.MX applications processor family […]
UP Fintech Holding Limited Reports Unaudited Third Quarter 2024 Financial Results
SINGAPORE, Nov. 12, 2024 (GLOBE NEWSWIRE) — UP Fintech Holding Limited (NASDAQ: TIGR) (“UP Fintech” or the “Company”), a leading […]
Shell welcomes Dutch Court of Appeal ruling
Shell plc Shell welcomes Dutch Court of Appeal ruling November 12, 2024 Today, the Court of Appeal of The Hague […]
NANOBIOTIX Provides Third Quarter 2024 Update and Progress on Nanotherapeutics Platforms
Transferred US sponsorship of global Phase 3 NANORAY-312 head and neck cancer study, a key step in the preparation for […]
BitFuFu Secures $100 Million Credit Line From Antpool Technologies
Singapore, Nov. 12, 2024 (GLOBE NEWSWIRE) — BitFuFu, Inc.. (NASDAQ: FUFU, FUFU.WS) (“BitFuFu” or the “Company”), a fast-growing digital asset […]
TSX News -
Valeura Implements Share Buyback Programme
SINGAPORE, Nov. 12, 2024 (GLOBE NEWSWIRE) — Valeura Energy Inc. (TSX:VLE, OTCQX:VLERF) (“Valeura” or the “Company”) is pleased to announce that […]
Belite Bio Reports Third Quarter 2024 Financial Results and Provides a Corporate Update
Dosed first patient in Phase 2/3 DRAGON II trial of Tinlarebant for the treatment of Stargardt disease (STGD1) Pivotal global […]
